Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 64
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
JAMA ; 331(22): 1918-1930, 2024 06 11.
Artículo en Inglés | MEDLINE | ID: mdl-38687503

RESUMEN

Importance: Among all US women, breast cancer is the second most common cancer and the second most common cause of cancer death. In 2023, an estimated 43 170 women died of breast cancer. Non-Hispanic White women have the highest incidence of breast cancer and non-Hispanic Black women have the highest mortality rate. Objective: The USPSTF commissioned a systematic review to evaluate the comparative effectiveness of different mammography-based breast cancer screening strategies by age to start and stop screening, screening interval, modality, use of supplemental imaging, or personalization of screening for breast cancer on the incidence of and progression to advanced breast cancer, breast cancer morbidity, and breast cancer-specific or all-cause mortality, and collaborative modeling studies to complement the evidence from the review. Population: Cisgender women and all other persons assigned female at birth aged 40 years or older at average risk of breast cancer. Evidence Assessment: The USPSTF concludes with moderate certainty that biennial screening mammography in women aged 40 to 74 years has a moderate net benefit. The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of screening mammography in women 75 years or older and the balance of benefits and harms of supplemental screening for breast cancer with breast ultrasound or magnetic resonance imaging (MRI), regardless of breast density. Recommendation: The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or MRI in women identified to have dense breasts on an otherwise negative screening mammogram. (I statement).


Asunto(s)
Neoplasias de la Mama , Detección Precoz del Cáncer , Mamografía , Humanos , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/prevención & control , Neoplasias de la Mama/diagnóstico por imagen , Femenino , Persona de Mediana Edad , Anciano , Adulto , Imagen por Resonancia Magnética , Factores de Edad , Ultrasonografía Mamaria , Estados Unidos , Tamizaje Masivo
2.
JAMA ; 331(11): 951-958, 2024 03 19.
Artículo en Inglés | MEDLINE | ID: mdl-38502069

RESUMEN

Importance: Child maltreatment, which includes child abuse and neglect, can have profound effects on health, development, survival, and well-being throughout childhood and adulthood. The prevalence of child maltreatment in the US is uncertain and likely underestimated. In 2021, an estimated 600 000 children were identified by Child Protective Services as experiencing abuse or neglect and an estimated 1820 children died of abuse and neglect. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate benefits and harms of primary care-feasible or referable behavioral counseling interventions to prevent child maltreatment in children and adolescents younger than 18 years without signs or symptoms of maltreatment. Population: Children and adolescents younger than 18 years who do not have signs or symptoms of or known exposure to maltreatment. Evidence Assessment: The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of primary care interventions to prevent child maltreatment in children and adolescents younger than 18 years without signs or symptoms of or known exposure to maltreatment. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care interventions to prevent child maltreatment. (I statement).


Asunto(s)
Maltrato a los Niños , Atención Primaria de Salud , Adolescente , Niño , Humanos , Comités Consultivos , Terapia Conductista , Maltrato a los Niños/mortalidad , Maltrato a los Niños/prevención & control , Servicios de Protección Infantil/estadística & datos numéricos , Atención Primaria de Salud/métodos , Derivación y Consulta , Medición de Riesgo , Estados Unidos/epidemiología
3.
Ann Intern Med ; 175(9): 1305-1309, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35914264

RESUMEN

DESCRIPTION: The Women's Preventive Services Initiative (WPSI), a national coalition of women's health professional organizations and patient advocacy representatives, developed a recommendation for counseling midlife women aged 40 to 60 years with normal or overweight body mass index (BMI; 18.5 to 29.9 kg/m2) to maintain weight or limit weight gain to prevent obesity with the long-term goals of optimizing health, function, and well-being. This recommendation is intended to guide clinical practice and coverage of clinical preventive health services for the Health Resources and Services Administration and other stakeholders. Clinicians providing preventive health care to women in primary care settings are the target audience for this recommendation. METHODS: The WPSI developed this recommendation after evaluating results of a systematic review of the effectiveness and harms of interventions to prevent weight gain and obesity in women aged 40 to 60 years without obesity. Seven randomized clinical trials including 51 638 participants and using various counseling and behavioral interventions were included. Trials indicated favorable weight changes with interventions that were statistically significantly different from control groups in 4 of 5 trials of counseling, but not in 2 trials of exercise. Few harms were reported. RECOMMENDATION: The WPSI recommends counseling midlife women aged 40 to 60 years with normal or overweight BMI (18.5 to 29.9 kg/m2) to maintain weight or limit weight gain to prevent obesity. Counseling may include individualized discussion of healthy eating and physical activity.


Asunto(s)
Sobrepeso , Servicios Preventivos de Salud , Femenino , Humanos , Obesidad/prevención & control , Sobrepeso/complicaciones , Sobrepeso/prevención & control , Aumento de Peso , Salud de la Mujer
4.
JAMA ; 330(8): 736-745, 2023 08 22.
Artículo en Inglés | MEDLINE | ID: mdl-37606666

RESUMEN

Importance: An estimated 1.2 million persons in the US currently have HIV, and more than 760 000 persons have died of complications related to HIV since the first cases were reported in 1981. Although treatable, HIV is not curable and has significant health consequences. Therefore, effective strategies to prevent HIV are an important public health and clinical priority. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of preexposure prophylaxis with antiretroviral therapy for the prevention of HIV acquisition, and the diagnostic accuracy of risk assessment tools to identify persons at increased risk of HIV acquisition. Population: Adolescents and adults who do not have HIV and are at increased risk of HIV. Evidence Assessment: The USPSTF concludes with high certainty that there is a substantial net benefit from the use of effective antiretroviral therapy to reduce the risk of acquisition of HIV in persons at increased risk of acquiring HIV. Recommendation: The USPSTF recommends that clinicians prescribe preexposure prophylaxis using effective antiretroviral therapy to persons at increased risk of HIV acquisition to decrease the risk of acquiring HIV. (A recommendation).


Asunto(s)
Antirretrovirales , Infecciones por VIH , Profilaxis Pre-Exposición , Adolescente , Adulto , Humanos , Comités Consultivos , Antirretrovirales/administración & dosificación , Antirretrovirales/efectos adversos , Antirretrovirales/uso terapéutico , Infecciones por VIH/diagnóstico , Infecciones por VIH/epidemiología , Infecciones por VIH/etiología , Infecciones por VIH/prevención & control , Profilaxis Pre-Exposición/métodos , Profilaxis Pre-Exposición/normas , Servicios Preventivos de Salud , Salud Pública , Medición de Riesgo/métodos , Medición de Riesgo/normas , Estados Unidos/epidemiología
5.
JAMA ; 329(23): 2057-2067, 2023 06 20.
Artículo en Inglés | MEDLINE | ID: mdl-37338872

RESUMEN

Importance: Major depressive disorder (MDD), a common mental disorder in the US, may have substantial impact on the lives of affected individuals. If left untreated, MDD can interfere with daily functioning and can also be associated with an increased risk of cardiovascular events, exacerbation of comorbid conditions, or increased mortality. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate benefits and harms of screening, accuracy of screening, and benefits and harms of treatment of MDD and suicide risk in asymptomatic adults that would be applicable to primary care settings. Population: Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for MDD in adults, including pregnant and postpartum persons and older adults, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on the benefit and harms of screening for suicide risk in adults, including pregnant and postpartum persons and older adults. Recommendation: The USPSTF recommends screening for depression in the adult population, including pregnant and postpartum persons and older adults. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in the adult population, including pregnant and postpartum persons and older adults. (I statement).


Asunto(s)
Trastorno Depresivo Mayor , Tamizaje Masivo , Suicidio , Adulto , Anciano , Femenino , Humanos , Masculino , Embarazo , Depresión/diagnóstico , Trastorno Depresivo Mayor/complicaciones , Trastorno Depresivo Mayor/diagnóstico , Tamizaje Masivo/efectos adversos , Tamizaje Masivo/métodos , Medición de Riesgo , Estados Unidos
10.
J Telemed Telecare ; 29(1): 3-9, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33081595

RESUMEN

INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic resulted in an unprecedented expansion in telehealth, but little is known about differential use of telehealth according to demographics, rurality, or insurance status. METHODS: We performed a cross-sectional analysis of 7742 family medicine encounters at a single USA institution in the initial month of the COVID-19 public health emergency (PHE). We compared the demographics of those using telehealth during the PHE to those with face-to-face visits during the same time period; we also compared the demographics of those using full audio-video to those using audio-only. RESULTS: The likelihood of any telehealth visit in the first 30 days of telehealth expansion was higher for women, those age 65 years and older, self-pay patients, and those with Medicaid and Medicare as primary payers. The likelihood of a telehealth visit was reduced for rural residence and Black or other races. Among all telehealth visits, the likelihood of a full audio-video telehealth visit was reduced for patients who were older, Black, from urban areas, or who were self-pay, Medicaid, or Medicare payer status. DISCUSSION: Significant disparities exist in telehealth use during the COVID-19 PHE by age, race, residence and payer.


Asunto(s)
COVID-19 , Telemedicina , Humanos , Estados Unidos/epidemiología , Femenino , Anciano , COVID-19/epidemiología , Medicare , Estudios Transversales , Salud Pública
11.
Am J Prev Med ; 57(1): 117-126, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-31130461

RESUMEN

CONTEXT: Age-adjusted death rates for heart disease are higher in rural areas than in urban areas. Lay advisors could potentially facilitate improvement in cardiovascular health outcomes. The aim of this systematic review and meta-analysis is to estimate lay advisor intervention effects on cardiovascular health metrics in rural populations. EVIDENCE ACQUISITION: Searches of databases including MEDLINE, CINAHL, and Scopus from 1975 through October 2017 retrieved 323 citations, of which 272 abstracts were reviewed. Two authors independently abstracted data from eligible studies. Analysis was conducted in March 2018. EVIDENCE SYNTHESIS: Of 21 articles included in the systematic review, eight were RCTs and 13 were pre- and post-intervention studies. Of the RCTs, three took place in the U.S. Only two studies had low risk of bias. Using a random effects model, meta-analysis of six RCTs (1,641 participants) showed that lay advisor interventions in rural residents were associated with improvement in HbA1c of 0.4% (95% CI=0.13, 0.66, p=0.004, I2=60.65%). From four RCTs (873 participants), lay advisor interventions significantly improved BMI with pooled effect of 2.18 (95% CI=1.13, 3.24, p<0.001, I2=0.00%). Most studies had normal baseline blood pressure and cholesterol levels before intervention, and no significant effects were noted for these outcomes. Diverse types of measures used for diet, physical activity, and smoking precluded statistical synthesis. CONCLUSIONS: Lay advisor interventions had significant positive effects on glycemic control and BMI for rural residents; however, further rigorous studies are needed in U.S. rural populations, and elements of effective lay advisor interventions require further investigation.


Asunto(s)
Agentes Comunitarios de Salud/psicología , Cardiopatías/psicología , Cardiopatías/terapia , Presión Sanguínea/fisiología , Dieta , Ejercicio Físico/fisiología , Humanos , Población Rural
12.
J Fam Pract ; 67(11): 704;706;707, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30481249

RESUMEN

Asthma may not be a permanent diagnosis in adults. A study finds that up to one-third of adults with physician-diagnosed asthma no longer had it after 5 years.


Asunto(s)
Asma , Adulto , Humanos
13.
J Fam Pract ; 67(6): 379-380, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29879238

RESUMEN

Allowing low-risk pregnant women to eat less restrictive diets during labor may not only make them happier, but may shorten labor, too.


Asunto(s)
Trabajo de Parto , Ingestión de Alimentos , Femenino , Humanos , Embarazo
18.
J Fam Pract ; 65(11): 754, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-28087878

RESUMEN

According to JAMA's retraction statement, the first author of the article admitted to data fabrication following an internal investigation.² The source article does not provide subgroup analysis to determine how much of an effect the fabricated data may have had on the final reported outcome.

19.
J Fam Pract ; 64(3): 182-4, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25789345

RESUMEN

Adding simvastatin to standard wound care improves ulcer healing rates and times as well as the patient's quality of life.


Asunto(s)
Fármacos Cardiovasculares/administración & dosificación , Fármacos Dermatológicos/administración & dosificación , Simvastatina/administración & dosificación , Úlcera Varicosa/tratamiento farmacológico , Femenino , Humanos , Masculino
20.
J Fam Pract ; 52(3): 185-6, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12620166

RESUMEN

C-reactive protein (CRP) is an independent predictor of a first cardiovascular event in women and appears to be a stronger predictor than low-density lipoprotein (LDL) cholesterol levels. Unfortunately, this information does not lead directly to a therapeutic intervention. As an accompanying editorial stated, low carotenoid levels also predict cardiovascular events, but supplementation with beta carotene does not reduce an individual's risk. This study does not clarify whether CRP is a causative agent, a marker, or a result of cardiovascular disease. Our focus should remain on identifying and treating conventional risk factors until we better understand the exact role CRP has in therapeutic decisions regarding cardiovascular disease.


Asunto(s)
Proteína C-Reactiva , Enfermedades Cardiovasculares/diagnóstico , LDL-Colesterol , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/prevención & control , Medicina Basada en la Evidencia , Femenino , Humanos , Guías de Práctica Clínica como Asunto , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA